JW Pharmaceutical

JW Pharmaceutical operates in the healthcare sector, focusing on the development and distribution of medical products and quasi drugs. The company is recognized as a leading player in the global pharmaceutical market, with a diverse portfolio that includes original medicines and medical supplies such as Livalo, Thrupas, Sigmart, and Actemra. Additionally, JW Pharmaceutical is committed to improving patient care by creating specialized dietary products, including low-protein and low-salt food options for individuals with chronic renal insufficiency. Through its comprehensive range of pharmaceutical and healthcare products, the company aims to meet the evolving needs of patients and healthcare providers.